Foundations Investment Advisors, LLC
EndowmentPosition in ESPR — Esperion Therapeutics, Inc.
CIK 1743404
PHOENIX, AZ
Position in ESPR
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$109,600
-$38,799 QoQ
Shares Held
40,000
-0.3% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in ESPR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Foundations Investment Advisors, LLC holds $318,400 across 2 Drug Manufacturers - Specialty & Generic names. ESPR ranks #2 (34.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CGC |
Canopy Growth Corp
|
220,022 | $208,800 | |
| 2 | ESPR |
Esperion Therapeutics, Inc.
This page
|
40,000 | $109,600 |
All Filings in ESPR
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $109,600 | 40,000 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $148,399 | 40,108 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $106,416 | 40,157 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $49,153 | 50,157 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $72,247 | 50,172 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $66,378 | 30,172 | Shares | Sole | 2025-01-22 | |
| 2024-09-30 | $33,495 | 20,300 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $44,400 | 20,000 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $53,600 | 20,000 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $59,800 | 20,000 | Shares | Sole | 2024-02-08 | |
| No filing history on record for this holder in this stock. | ||||||